Overview

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Status:
RECRUITING

Trial end date:
2027-01-31

Target enrollment:

Participant gender:

Summary

The purpose is to evaluate the efficacy of ondansetron oral soluble film plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) with MEC/HEC chemotherapy in children with solid tumor.

Phase:

PHASE3

Details

Lead Sponsor:

Yizhuo Zhang

Treatments:

Dexamethasone
Injections
Ondansetron